Synergistic and antagonistic drug combinations against SARS-CoV-2 T Bobrowski, L Chen, RT Eastman, Z Itkin, P Shinn, CZ Chen, H Guo, ... Molecular Therapy 29 (2), 873-885, 2021 | 109* | 2021 |
QSAR modeling of SARS‐CoV Mpro inhibitors identifies Sufugolix, Cenicriviroc, Proglumetacin and other drugs as candidates for repurposing against SARS‐CoV‐2 V Alves, T Bobrowski, C Melo-Filho, D Korn, S Auerbach, C Schmitt, ... Molecular Informatics, 2020 | 90* | 2020 |
Learning from history: do not flatten the curve of antiviral research! T Bobrowski, CC Melo-Filho, D Korn, VM Alves, KI Popov, S Auerbach, ... Drug Discovery Today 25 (9), 1604-1613, 2020 | 36 | 2020 |
COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database D Korn, T Bobrowski, M Li, Y Kebede, P Wang, P Owen, G Vaidya, ... Bioinformatics 37 (4), 586-587, 2021 | 23 | 2021 |
Conserved coronavirus proteins as targets of broad-spectrum antivirals CC Melo-Filho, T Bobrowski, HJ Martin, Z Sessions, KI Popov, ... Antiviral Research 204, 105360, 2022 | 18 | 2022 |
Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents JE Hochuli, S Jain, C Melo-Filho, ZL Sessions, T Bobrowski, J Choe, ... ACS Pharmacology & Translational Science 5 (7), 468-478, 2022 | 7 | 2022 |
ZINC express: a virtual assistant for purchasing compounds annotated in the ZINC database TM Bobrowski, DR Korn, EN Muratov, A Tropsha Journal of Chemical Information and Modeling 61 (3), 1033-1036, 2021 | 7 | 2021 |
Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing P Cohen, EJ DeGrace, O Danziger, RS Patel, EA Barrall, T Bobrowski, ... Microbiology Spectrum 11 (5), e00776-23, 2023 | 5 | 2023 |
COVID-19 Knowledge Extractor (COKE): A Curated Repository of Drug–Target Associations Extracted from the CORD-19 Corpus of Scientific Publications on COVID-19 D Korn, V Pervitsky, T Bobrowski, VM Alves, C Schmitt, C Bizon, N Baker, ... Journal of Chemical Information and Modeling 61 (12), 5734-5741, 2021 | 5* | 2021 |
Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks? Z Sessions, T Bobrowski, HJ Martin, JMT Beasley, A Kothari, T Phares, ... FEMS Microbiology Reviews 47 (5), fuad048, 2023 | 4* | 2023 |
Sequence and structure conservation analysis of the key coronavirus proteins supports the feasibility of discovering broad-spectrum antiviral medications. C Melo-Filho, T Bobrowski, HJ Martin, Z Sessions, K Popov, N Moorman, ... | 1 | 2022 |
Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents (preprint) JE Hochuli, S Jain, C Melo-Filho, ZL Sessions, T Bobrowski, J Choe, ... | | 2022 |
Computational Models Identify Several FDA Approved or Experimental Drugs as Putative Agents Against SARS-CoV-2 (preprint) T Bobrowski, V Alves, CC Melo-Filho, D Korn, SS Auerbach, C Schmitt, ... | | 2020 |
COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database (preprint) D Korn, T Bobrowski, M Li, Y Kebede, P Wang, P Owen, G Vaidya, ... | | 2020 |